These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18220604)

  • 1. Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model.
    Tomino Y; Tanimoto M; Shike T; Shiina K; Fan Q; Liao J; Gohda T; Makita Y; Funabiki K
    Curr Diabetes Rev; 2005 Aug; 1(3):281-6. PubMed ID: 18220604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice.
    Shike T; Gohda T; Tanimoto M; Kobayashi M; Makita Y; Funabiki K; Horikoshi S; Hirose S; Shirai T; Tomino Y
    Nephrol Dial Transplant; 2005 May; 20(5):879-85. PubMed ID: 15769825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
    Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of quantitative trait loci for diabetic nephropathy in KK-Ay/Ta mice.
    Aoki T; Kaneko S; Tanimoto M; Gohda T; Hagiwara S; Murakoshi M; Ishikawa Y; Furukawa M; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(1):127-36. PubMed ID: 21725918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mouse cholinephosphotransferase gene expression in kidneys of type 2 diabetic KK/TA mouse.
    Gohda T; Tanimoto M; Shiina K; Ito T; Kobayashi M; Hagiwara S; Kaneko S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    Metabolism; 2004 Jul; 53(7):842-6. PubMed ID: 15254874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profile in diabetic KK/Ta mice.
    Fan Q; Shike T; Shigihara T; Tanimoto M; Gohda T; Makita Y; Wang LN; Horikoshi S; Tomino Y
    Kidney Int; 2003 Dec; 64(6):1978-85. PubMed ID: 14633120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
    Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model.
    Shike T; Hirose S; Kobayashi M; Funabiki K; Shirai T; Tomino Y
    Diabetes; 2001 Aug; 50(8):1943-8. PubMed ID: 11473059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
    Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.
    Tanimoto M; Fan Q; Gohda T; Shike T; Makita Y; Tomino Y
    Metabolism; 2004 Nov; 53(11):1473-9. PubMed ID: 15536604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Ohara I; Tanimoto M; Gohda T; Yamazaki T; Hagiwara S; Murakoshi M; Aoki T; Toyoda H; Ishikawa Y; Funabiki K; Horikoshi S; Tomino Y
    Nephron Exp Nephrol; 2011; 117(4):e124-32. PubMed ID: 20948237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse.
    Lubec B; Aufricht C; Amann G; Kitzmüller E; Höger H
    Nephron; 1997; 75(2):213-8. PubMed ID: 9041544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.
    Parving HH; Andersen S; Jacobsen P; Christensen PK; Rossing K; Hovind P; Rossing P; Tarnow L
    Semin Nephrol; 2004 Mar; 24(2):147-57. PubMed ID: 15017527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy.
    Furukawa M; Gohda T; Tanimoto M; Tomino Y
    ScientificWorldJournal; 2013; 2013():928197. PubMed ID: 23737732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic Nephropathy.
    Tomino Y
    Nephrourol Mon; 2012; 4(3):524-9. PubMed ID: 23573479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice.
    Tahara A; Takasu T
    Eur J Pharmacol; 2018 Jul; 830():68-75. PubMed ID: 29702076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity?
    Gohda T; Makita Y; Shike T; Tanimoto M; Funabiki K; Horikoshi S; Tomino Y
    Diabetes; 2003 Aug; 52(8):2175-81. PubMed ID: 12882938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.
    Qi Z; Fujita H; Jin J; Davis LS; Wang Y; Fogo AB; Breyer MD
    Diabetes; 2005 Sep; 54(9):2628-37. PubMed ID: 16123351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor gene effect of leptin receptor variant on the body weight in KK/Ta mice.
    Gohda T; Tanimoto M; Kaneko S; Shibata T; Funabiki K; Horikoshi S; Tomino Y
    Diabetes Obes Metab; 2006 Sep; 8(5):581-4. PubMed ID: 16918594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.